SPHERA FUNDS MANAGEMENT LTD. - Q4 2022 holdings

$466 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 64 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 64.9% .

 Value Shares↓ Weighting
NewINVESCO QQQ TRcall$61,510,680231,000
+100.0%
13.20%
SellINVESCO QQQ TRput$55,918,800
-35.7%
210,000
-35.5%
12.00%
-0.6%
AZN SellASTRAZENECA PLCsponsored adr$27,124,068
-44.9%
400,060
-55.4%
5.82%
-14.7%
SNY SellSANOFIsponsored adr$27,097,311
-41.3%
559,515
-53.9%
5.82%
-9.3%
BuyTEVA PHARMACEUTICAL INDS LTDcall$20,267,376
+13.6%
2,222,300
+0.6%
4.35%
+75.7%
JNJ SellJOHNSON & JOHNSON$19,401,646
-45.1%
109,831
-49.2%
4.16%
-15.0%
SNDX SellSYNDAX PHARMACEUTICALS INC$18,083,777
-8.5%
710,561
-13.6%
3.88%
+41.4%
MRK SellMERCK & CO INC$13,380,570
-57.7%
120,600
-67.1%
2.87%
-34.5%
CRNX BuyCRINETICS PHARMACEUTICALS IN$12,291,085
-0.1%
671,644
+7.2%
2.64%
+54.4%
ALBO BuyALBIREO PHARMA INC$10,023,323
+44.2%
463,828
+29.2%
2.15%
+122.9%
ABBV SellABBVIE INC$9,696,600
-55.5%
60,000
-63.0%
2.08%
-31.2%
NVO SellNOVO-NORDISK A Sadr$9,682,224
-67.2%
71,540
-75.9%
2.08%
-49.3%
LLY SellLILLY ELI & CO$9,398,430
-79.8%
25,690
-82.1%
2.02%
-68.7%
KZR BuyKEZAR LIFE SCIENCES INC$9,188,446
-14.3%
1,305,183
+4.8%
1.97%
+32.4%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$8,510,636
+18.3%
183,696
+5.8%
1.83%
+83.1%
SWTX BuySPRINGWORKS THERAPEUTICS INC$8,235,416
-4.3%
316,625
+5.0%
1.77%
+48.1%
KROS SellKEROS THERAPEUTICS INC$7,623,511
-2.0%
158,757
-23.2%
1.64%
+51.5%
SellARCELLX INC$7,357,378
+17.3%
237,488
-28.9%
1.58%
+81.5%
NewASTRIA THERAPEUTICS INC$6,988,473469,340
+100.0%
1.50%
NewTOWER SEMICONDUCTOR LTDput$6,981,120161,600
+100.0%
1.50%
PNT SellPOINT BIOPHARMA GLOBAL INC$6,944,760
-14.7%
952,642
-9.5%
1.49%
+31.9%
KURA SellKURA ONCOLOGY INC$6,928,342
-35.8%
558,287
-29.3%
1.49%
-0.7%
IMTX SellIMMATICS N.V$6,801,221
-14.5%
780,852
-1.8%
1.46%
+32.2%
BuyCINCOR PHARMA INC$6,509,276
+66.7%
529,640
+345.3%
1.40%
+157.7%
FIVN NewFIVE9 INC$6,446,60095,000
+100.0%
1.38%
ALT SellALTIMMUNE INC$6,255,902
-18.4%
380,298
-36.6%
1.34%
+26.2%
CNCE BuyCONCERT PHARMACEUTICALS INC$5,856,253
-8.3%
1,002,783
+5.2%
1.26%
+41.9%
XBI NewSPDR SER TRs&p biotech$5,810,00070,000
+100.0%
1.25%
GNRC NewGENERAC HLDGS INC$5,032,99550,000
+100.0%
1.08%
MRUS BuyMERUS N V$4,903,882
-21.9%
316,993
+1.2%
1.05%
+20.8%
KNSA NewKINIKSA PHARMACEUTICALS LTD$4,603,099307,283
+100.0%
0.99%
NewLEONARDO DRS INC$4,288,418335,557
+100.0%
0.92%
ISEE SellIVERIC BIO INC$4,187,603
-59.9%
195,591
-66.4%
0.90%
-38.0%
BLU BuyBELLUS HEALTH INC NEW$4,026,649
-18.0%
489,860
+5.4%
0.86%
+26.9%
 FIVERR INTL LTDnote 11/0$4,013,955
+2.9%
4,951,0000.0%0.86%
+59.1%
RIGL BuyRIGEL PHARMACEUTICALS INC$3,418,268
+33.9%
2,278,845
+5.4%
0.73%
+107.3%
KDNY SellCHINOOK THERAPEUTICS INC$3,332,640
-68.3%
127,200
-76.2%
0.72%
-51.0%
NewAPELLIS PHARMACEUTICALS INCput$3,102,60060,000
+100.0%
0.67%
CAMT NewCAMTEK LTDord$2,415,600110,000
+100.0%
0.52%
RZLT  REZOLUTE INC$2,392,707
-24.4%
1,155,8970.0%0.51%
+16.8%
ETNB Sell89BIO INC$2,299,038
-39.7%
180,600
-72.6%
0.49%
-6.8%
BIIB SellBIOGEN INC$2,081,331
-86.0%
7,516
-86.5%
0.45%
-78.3%
STOK BuySTOKE THERAPEUTICS INC$1,741,147
-13.7%
188,640
+20.0%
0.37%
+33.6%
INZY BuyINOZYME PHARMA INC$1,706,311
-45.8%
1,625,058
+38.3%
0.37%
-16.2%
PMVP  PMV PHARMACEUTICALS INC$1,633,860
-26.9%
187,8000.0%0.35%
+13.2%
BCAB NewBIOATLA INC$1,539,450186,600
+100.0%
0.33%
ALPN  ALPINE IMMUNE SCIENCES INC$1,470,000
+2.1%
200,0000.0%0.32%
+57.5%
HOWL  WEREWOLF THERAPEUTICS INC$1,284,961
-54.5%
626,8100.0%0.28%
-29.6%
NewMEDIWOUND LTD$1,017,32175,413
+100.0%
0.22%
AUTL NewAUTOLUS THERAPEUTICS PLCspon ads$950,000500,000
+100.0%
0.20%
AMAT NewAPPLIED MATLS INC$827,5588,499
+100.0%
0.18%
INFI  INFINITY PHARMACEUTICALS INC$819,180
-53.3%
1,476,0000.0%0.18%
-27.9%
 NICE SYS INCnote 1.250% 1/1$576,550
+1.0%
250,0000.0%0.12%
+57.0%
TBLA NewTABOOLA.COM LTD$369,600120,000
+100.0%
0.08%
MGIC SellMAGIC SOFTWARE ENTERPRISES Lord$352,199
-72.2%
21,981
-73.0%
0.08%
-56.8%
IMTXW  IMMATICS N.V*w exp 07/01/202$251,000
-7.4%
100,0000.0%0.05%
+42.1%
AGLE NewAEGLEA BIOTHERAPEUTICS INC$198,333440,837
+100.0%
0.04%
CYCC  CYCLACEL PHARMACEUTICALS INC$166,750
-54.3%
250,0000.0%0.04%
-29.4%
 OTONOMO TECHNOLOGIES LTDordinary shares$159,488
+43.7%
391,8630.0%0.03%
+126.7%
 ARBE ROBOTICS LTDordinary shares$147,193
-43.2%
43,1650.0%0.03%
-11.1%
ONCR  ONCORUS INC$136,847
-70.2%
540,2580.0%0.03%
-54.7%
DYN NewDYNE THERAPEUTICS INC$82,8577,149
+100.0%
0.02%
New89BIO INCcall$45,8283,600
+100.0%
0.01%
NewOUTBRAIN INC$43,97612,148
+100.0%
0.01%
U ExitUNITY SOFTWARE INC$0-11,500
-100.0%
-0.05%
ExitWIX COM LTDnote 8/1$0-700,000
-100.0%
-0.08%
EWTX ExitEDGEWISE THERAPEUTICS INC$0-60,000
-100.0%
-0.08%
NICE ExitNICE LTDsponsored adr$0-3,145
-100.0%
-0.08%
ICL ExitICL GROUP LTD$0-111,482
-100.0%
-0.13%
MDWD ExitMEDIWOUND LTD$0-688,716
-100.0%
-0.13%
PSTX ExitPOSEIDA THERAPEUTICS INC$0-300,000
-100.0%
-0.15%
VRNA ExitVERONA PHARMA PLCsponsored ads$0-120,000
-100.0%
-0.17%
ExitALTIMMUNE INCput$0-100,000
-100.0%
-0.18%
RUN ExitSUNRUN INC$0-65,000
-100.0%
-0.25%
ExitDICE THERAPEUTICS INCput$0-150,000
-100.0%
-0.42%
ExitDICE THERAPEUTICS INC$0-152,913
-100.0%
-0.43%
ExitRELMADA THERAPEUTICS INCput$0-93,000
-100.0%
-0.48%
ExitSENTINELONE INCcall$0-164,800
-100.0%
-0.58%
NVDA ExitNVIDIA CORPORATION$0-40,000
-100.0%
-0.67%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDsponsored ads$0-776,346
-100.0%
-0.87%
ExitGENERAC HLDGS INCcall$0-35,600
-100.0%
-0.88%
GILD ExitGILEAD SCIENCES INC$0-105,090
-100.0%
-0.90%
SEDG ExitSOLAREDGE TECHNOLOGIES INC$0-29,426
-100.0%
-0.94%
RLMD ExitRELMADA THERAPEUTICS INC$0-193,230
-100.0%
-0.99%
S ExitSENTINELONE INCcl a$0-280,000
-100.0%
-0.99%
ExitPERION NETWORK LTD$0-405,184
-100.0%
-1.08%
ADBE ExitADOBE SYSTEMS INCORPORATED$0-29,150
-100.0%
-1.11%
GLBE ExitGLOBAL E ONLINE LTD$0-311,460
-100.0%
-1.16%
KRNT ExitKORNIT DIGITAL LTD$0-322,926
-100.0%
-1.19%
WIX ExitWIX COM LTD$0-129,000
-100.0%
-1.40%
PANW ExitPALO ALTO NETWORKS INC$0-63,000
-100.0%
-1.43%
ExitUNITY SOFTWARE INCcall$0-367,500
-100.0%
-1.62%
ExitNVIDIA CORPORATIONcall$0-172,600
-100.0%
-2.91%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TEVA PHARMACEUTICAL-SP ADR36Q3 20238.4%
MERCK & CO INC NEW35Q3 20238.4%
NICE Systems Ltd27Q3 20234.4%
BIOGEN INC26Q3 20236.7%
AMICUS THERAPEUTICS INC26Q2 20224.3%
PFIZER INC25Q3 20239.2%
SAREPTA THERAPEUTICS INC25Q3 20233.2%
JOHNSON & JOHNSON24Q3 20238.0%
UNIQURE NV23Q3 20231.2%
SYNDAX PHARMACEUTICALS INC22Q3 20233.9%

View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)

View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G2024-02-08
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G/A2024-02-05
13F-HR2023-11-14
SC 13G2023-10-10
SC 13G2023-08-30

View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.

Compare quarters

Export SPHERA FUNDS MANAGEMENT LTD.'s holdings